Company Overview
Snapshot
Founded in December 2021 by Nikita Shenkar, Gaia Bio operates with 1–10 employees. The company has secured funding across three rounds from VentureIsrael, with its latest funding round occurring in September 2025.
Business overview
Gaia Bio specializes in industrial biotechnology, leveraging a novel gene-editing technology and proprietary methodology to enhance precision fermentation processes and improve bacterial bioremediation and biomining. The company's approach allows for the engineering of a broad spectrum of environmental bacteria, a critical capability for applications requiring bacteria to thrive in challenging conditions like acidic environments. Gaia Bio's technology aims to increase the yield of bacteria-based products and addresses complex environmental and sustainability challenges across various industries, including wastewater treatment, plastic remediation, alternative batteries, sustainable chemicals, metals recovery, and sustainable agriculture.
Log in to access full profile ›Company Intelligence Q&A
- When was Gaia Bio founded?
- Gaia Bio was founded in December 2021.
- Who is the founder of Gaia Bio?
- Nikita Shenkar is the Co-founder & CEO of Gaia Bio.
- What is Gaia Bio's primary focus?
- Gaia Bio focuses on using gene-editing technology to increase yields in precision fermentation and enhance bacterial bioremediation and biomining processes.
- Which investor has supported Gaia Bio?
- VentureIsrael has invested in Gaia Bio, providing follow-on funding in October 2024 and September 2025.
- What types of environmental challenges does Gaia Bio address?
- Gaia Bio engineers bacteria to address complex environmental and sustainability challenges, including wastewater treatment, plastic and pollution treatment, and metal recovery and refinery.